Page last updated: 2024-12-07

dimyristoylphosphatidylserine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID123699
SCHEMBL ID25552
MeSH IDM0126353

Synonyms (18)

Synonym
1,2-ditetradecanoyl-sn-glycero-3-phosphoserine
LMGP03010028
serine, 2,3-bis[(1-oxotetradecyl)oxy]propyl hydrogen phosphate (ester), (r)-
dl-serine, 2,3-bis[(1-oxotetradecyl)oxy]propyl hydrogen phosphate (ester), (r)
ps(14:0/14:0)
dimyristoyl phosphatidylserine
64023-32-1
dmpse
phosphatidylserine(28:0)
l-serine, 2,3-bis((1-oxotetradecyl)oxy)propyl hydrogen phosphate (ester), (r)-
dimyristoylphosphatidylserine
SCHEMBL25552
1,2-dimyristoyl-sn-glycero-3-phospho-l-serine
DTXSID00214009
pser(28:0)
1-myristoyl-2-myristoyl-sn-glycero-3-phosphoserine
phosphatidylserine(14:0/14:0)
pser(14:0/14:0)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Pathways (20)

PathwayProteinsCompounds
phospholipid biosynthesis CL(16:0/16:0/14:0/14:0)1121
phospholipid biosynthesis (CL(19:0cycv8c/16:0/14:0/14:0))1119
phospholipid biosynthesis (CL(19:0cycv8c/16:1(9Z)/14:0/14:0))1119
phospholipid biosynthesis (CL(19:0cycv8c/18:1(9Z)/14:0/14:0))917
phospholipid biosynthesis (CL(18:1(9Z)/14:0/14:0/18:1(9Z)))1120
phospholipid biosynthesis (CL(18:1(9Z)/14:0/18:1(9Z)/14:0))1120
phospholipid biosynthesis (CL(18:1(9Z)/16:0/14:0/14:0))1121
phospholipid biosynthesis (CL(18:1(9Z)/16:1(9Z)/14:0/14:0))1121
phospholipid biosynthesis (CL(18:1(9Z)/18:1(9Z)/14:0/14:0))1120
phospholipid biosynthesis (CL(10:0(3-OH)/17:0cycw7c/14:0/14:0))1119
phospholipid biosynthesis (CL(14:0(3-OH)/17:0cycw7c/14:0/14:0))817
Lysolipid Incorporation into Mitochondria514
Lysolipid Incorporation into ER1023
Lysolipid Incorporation into ER PC(14:0/14:0)1023
Lysolipid Incorporation into ER PC(18:2(9Z,11Z)/18:2(9Z,11Z))1019
Lysolipid incorporation into Mitochondria PC(14:0/14:0)514
Lysolipid incorporation into Mitochondria PC(18:2(9Z,11Z)/18:2(9Z,11Z))510
Phosphatidylcholine Biosynthesis PC(14:0/14:0)620
Phosphatidylethanolamine Biosynthesis PE(14:0/14:0)516
Phosphatidylcholine/Phosphatidylethanolamine Biosynthesis PC(14:0/14:0) | PE(14:0/14:0)617

Research

Studies (59)

TimeframeStudies, This Drug (%)All Drugs %
pre-199015 (25.42)18.7374
1990's19 (32.20)18.2507
2000's10 (16.95)29.6817
2010's13 (22.03)24.3611
2020's2 (3.39)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.52

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.52 (24.57)
Research Supply Index4.11 (2.92)
Research Growth Index4.63 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.52)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other60 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]